SCHEMBL7466587

SCHEMBL7466587

COc1nc2cc(Cl)c(Cl)c(NS(C)(=O)=O)c2nc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 8/20 0.36
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ACLY P53396 1/20 0.34
GLP1R P43220 2/20 0.33
PIK3CA P42336 2/20 0.33
LRRK2 Q5S007 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
NPY1R P25929 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475650 0.89 CCR4 (0.35) CCR4KDM4EMEN1NPC1MAPT
SCHEMBL7467654 0.89 NPY1R (0.37) CCR4HSD17B10ACLYPIK3CASMN1; SMN2
SCHEMBL7468793 0.88 CCR4 (0.36) CCR4PIK3CASMN1; SMN2HIF1AALDH1A1
SCHEMBL7476942 0.88 ALDH1A1 (0.38) CCR4KDM4EMEN1NPC1MAPT
SCHEMBL7462801 0.86 CCR4 (0.36) CCR4HPGDHSD17B10GLP1RPIK3CA
SCHEMBL7465420 0.85 SMN1; SMN2 (0.33) CCR4KDM4EMAPTHSD17B10PIK3CA
SCHEMBL7470948 0.84 GLP1R (0.33) CCR4KDM4EMEN1NPC1MAPT
SCHEMBL7472870 0.83 SLC40A1 (0.45) CCR4KDM4EMEN1MAPTKMT2A
SCHEMBL8935311 0.82 SMN1; SMN2 (0.32) CCR4KDM4EMAPTPIK3CASMN1; SMN2
SCHEMBL7468982 0.79 ALDH1A1 (0.45) KDM4EMEN1NPC1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed